{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:20:10Z","timestamp":1792891210134,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.gtc.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:30:20Z","timestamp":1494635420000},"page":"297-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Antibody-Mediated Rejection After Liver Transplant"],"prefix":"10.1016","volume":"46","author":[{"given":"Michael","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000658-196809000-00009","article-title":"Orthotopic homotransplantation of the human liver","volume":"168","author":"Starzl","year":"1968","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0016-5085(79)90294-4","article-title":"Fifteen years of clinical liver transplantation","volume":"77","author":"Starzl","year":"1979","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hep.1840020516","article-title":"Evolution of liver transplantation","volume":"2","author":"Starzl","year":"1982","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.005_bib4","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI66465","article-title":"A\u00a0modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker\u223cDebakey Clinical Medical Research Award","volume":"122","author":"Hurst","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/gut.2006.093195","article-title":"Life expectancy of adult liver allograft recipients in the UK","volume":"56","author":"Barber","year":"2007","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.005_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gut.2006.111369","article-title":"Survival after liver transplantation in the United Kingdom and Ireland compared with the United States","volume":"56","author":"Dawwas","year":"2007","journal-title":"Gut"},{"issue":"5 Pt 2","key":"10.1016\/j.gtc.2017.01.005_bib7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1600-6143.2007.01782.x","article-title":"Liver and intestine transplantation in the United States, 1996-2005","volume":"7","author":"Pomfret","year":"2007","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.005_bib8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2471\/BLT.06.039370","article-title":"The state of the international organ trade: a provisional picture based on integration of available information","volume":"85","author":"Shimazono","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.005_bib9","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/lt.21668","article-title":"Report of the Paris consensus meeting on expanded criteria donors in liver transplantation","volume":"14","author":"Durand","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0029-1192052","article-title":"Liver transplantation: the current situation","volume":"29","author":"Adam","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.005_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1097\/00007890-200206150-00022","article-title":"Lymphocyte apoptosis and cell replacement in human liver allografts","volume":"73","author":"Clouston","year":"2002","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007890-198702000-00025","article-title":"Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts","volume":"43","author":"Gouw","year":"1987","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.005_bib13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/lt.20242","article-title":"Detection of recipient\u2019s cells in liver graft using antibodies to mismatched HLA class I antigens","volume":"10","author":"Grassi","year":"2004","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.1840380425","article-title":"High frequency of chimerism in transplanted livers","volume":"38","author":"Ng","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.005_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1399-0039.2007.00834.x","article-title":"Allorecognition and the alloresponse: clinical implications","volume":"69","author":"Afzali","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.gtc.2017.01.005_bib16","series-title":"MacSween\u2019s pathology of the liver - transplantation pathology","first-page":"873","author":"Hubscher","year":"2012"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MOT.0000000000000194","article-title":"ABO-compatible liver allograft antibody-mediated rejection: an update","volume":"20","author":"Demetris","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007890-198409000-00018","article-title":"The detailed distribution of HLA-A, B, C antigens in normal human organs","volume":"38","author":"Daar","year":"1984","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0008-8749(84)90289-2","article-title":"Distribution of the major histocompatibility complex antigens on different cellular components of human liver","volume":"85","author":"Lautenschlager","year":"1984","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib20","first-page":"35","article-title":"HLA-A, B,C, HLA-D\/DR and HLA-D\/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease","volume":"70","author":"Ballardini","year":"1987","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.005_bib21","first-page":"993","article-title":"HLA-DR expression on the microvasculature of portal tracts in idiopathic portal hypertension. Immunohistochemical characteristics and relation to portal phlebosclerosis","volume":"115","author":"Terada","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.gtc.2017.01.005_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2013.00476","article-title":"CIITA and its dual roles in MHC gene transcription","volume":"4","author":"Devaiah","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.gtc.2017.01.005_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.rinim.2012.09.001","article-title":"Contrasting effects of IFN\u03b1 on MHC class II expression in professional vs. nonprofessional APCs: role of CIITA type IV promoter","volume":"2","author":"Pisapia","year":"2012","journal-title":"Results Immunol"},{"key":"10.1016\/j.gtc.2017.01.005_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13909","article-title":"2016 Comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ajt.13476","article-title":"Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts","volume":"16","author":"O\u2019Leary","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib27","first-page":"648","article-title":"Terminology for hepatic allograft rejection. International Working Party","volume":"22","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2007-1007376","article-title":"Immunopathology of antibodies as effectors of orthotopic liver allograft rejection","volume":"12","author":"Demetris","year":"1992","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.005_bib29","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/jlts.2003.50236","article-title":"Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?","volume":"9","author":"Ge","year":"2003","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.TP.0000132324.14207.8B","article-title":"Description of B lymphocytes and plasma cells, complement, and chemokines\/receptors in acute liver allograft rejection","volume":"78","author":"Krukemeyer","year":"2004","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.trim.2009.06.004","article-title":"Vascular deposition of complement C4d is increased in liver allografts with chronic rejection","volume":"21","author":"Martelius","year":"2009","journal-title":"Transpl Immunol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.gtc.2017.01.005_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-493-7_2","article-title":"Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury","volume":"1034","author":"Valenzuela","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.005_bib34","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.1201434","article-title":"HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging Fc\u03b3Rs","volume":"190","author":"Valenzuela","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.005_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.tp.0000266689.93615.cd","article-title":"Peritubular capillary rarefaction and lymphangiogenesis in chronic allograft failure","volume":"83","author":"Adair","year":"2007","journal-title":"Transplantation"},{"issue":"16","key":"10.1016\/j.gtc.2017.01.005_bib36","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCULATIONAHA.108.834739","article-title":"Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts","volume":"120","author":"Escaned","year":"2009","journal-title":"Circulation"},{"issue":"5 Pt 2","key":"10.1016\/j.gtc.2017.01.005_bib37","first-page":"H1486","article-title":"Effect of microvascular rarefaction on tissue oxygen delivery in hypertension","volume":"262","author":"Greene","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.gtc.2017.01.005_bib38","first-page":"582902","article-title":"Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection","volume":"2014","author":"Li","year":"2014","journal-title":"J\u00a0Immunol Res"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib39","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.2002.00309.x","article-title":"Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis","volume":"61","author":"Shimizu","year":"2002","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.005_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.humimm.2012.07.334","article-title":"Targeting the intragraft microenvironment and the development of chronic allograft rejection","volume":"73","author":"Dormond","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.gtc.2017.01.005_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fimmu.2012.00054","article-title":"Key features of the intragraft microenvironment that determine long-term survival following transplantation","volume":"3","author":"Bruneau","year":"2012","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.TP.0000149337.40911.E4","article-title":"Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation","volume":"79","author":"Usuda","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","article-title":"Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation","volume":"12","author":"Haga","year":"2006","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"issue":"1 Pt 2","key":"10.1016\/j.gtc.2017.01.005_bib45","first-page":"2217","article-title":"Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers","volume":"21","author":"Demetris","year":"1989","journal-title":"Transplant Proc"},{"issue":"8714","key":"10.1016\/j.gtc.2017.01.005_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0140-6736(90)92082-S","article-title":"Liver transplantation across ABO blood group barriers","volume":"336","author":"Gugenheim","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.005_bib48","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.23948","article-title":"Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.005_bib49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1440-1827.1999.00959.x","article-title":"Peribiliary capillary plexus around interlobular bile ducts in various chronic liver diseases: An immunohistochemical and morphometric study","volume":"49","author":"Matsunaga","year":"1999","journal-title":"Pathol Int"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840160310","article-title":"A\u00a0clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies","volume":"16","author":"Demetris","year":"1992","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jcp.42.4.360","article-title":"Massive haemorrhagic necrosis of the liver after liver transplantation","volume":"42","author":"H\u00fcbscher","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1432-2277.1995.tb01701.x","article-title":"Fulminant hepatic failure post liver transplantation: clinical syndromes, correlations and outcomes","volume":"8","author":"McCaughan","year":"1995","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.gtc.2017.01.005_bib53","first-page":"501","article-title":"Early fulminant graft failure in orthotopic liver transplantation with massive haemorrhagic necrosis","volume":"27","author":"Zimmermann","year":"1995","journal-title":"Ital J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib54","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.transproceed.2006.03.018","article-title":"Significance of C4d deposition in the diagnosis of rejection after liver transplantation","volume":"38","author":"Bu","year":"2006","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.005_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/modpathol.3800784","article-title":"Significance of C4d staining in ABO-identical\/compatible liver transplantation","volume":"20","author":"Sakashita","year":"2007","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1399-0012.2006.00528.x","article-title":"Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies","volume":"20","author":"Jain","year":"2006","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.005_bib57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.humpath.2007.12.014","article-title":"An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases","volume":"39","author":"Bouron-Dal Soglio","year":"2008","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.005_bib58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American Association for the Study of Liver Diseases. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.005_bib60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2014.166","article-title":"A\u00a0systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection","volume":"87","author":"Sapir-Pichhadze","year":"2015","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.005_bib62","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.5858\/2006-130-1489-EOCSIL","article-title":"Evaluation of C4d staining in liver and small intestine allografts","volume":"130","author":"Troxell","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lt.22233","article-title":"Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies","volume":"17","author":"Kozlowski","year":"2011","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/lt.23789","article-title":"Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation","volume":"20","author":"Salah","year":"2014","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation","volume":"11","author":"Musat","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.005_bib66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2559.2007.02677.x","article-title":"C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status","volume":"50","author":"Bellamy","year":"2007","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00428-005-1245-z","article-title":"Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection","volume":"447","author":"Dankof","year":"2005","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib68","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.transproceed.2011.03.043","article-title":"Antibody-mediated response in rat liver chronic rejection","volume":"43","author":"Wan","year":"2011","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.005_bib69","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.transproceed.2013.02.045","article-title":"Chronic antibody-mediated responses may mediate chronic rejection in rat orthotopic liver transplantation","volume":"45","author":"Shimizu","year":"2013","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.005_bib70","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.gtc.2017.01.005_bib71","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/TP.0000000000000638","article-title":"Long-term clinical relevance of de novo donor-specific antibodies after pediatric liver transplantation","volume":"99","author":"Grabhorn","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2017.01.005_bib72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.12659\/AOT.892544","article-title":"Immunological factors and liver fibrosis in pediatric liver transplant recipients","volume":"20","author":"Markiewicz-Kijewska","year":"2015","journal-title":"Ann Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/lt.23565","article-title":"Low-dose steroids associated with milder histological changes after pediatric liver transplantation","volume":"19","author":"Kosola","year":"2013","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.005_bib74","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1097\/TP.0000000000000796","article-title":"Donor-specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation","volume":"99","author":"Wozniak","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib75","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/TP.0b013e318195a7cb","article-title":"Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation","volume":"87","author":"Yoshitomi","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.trim.2006.10.004","article-title":"Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation","volume":"17","author":"Koshiba","year":"2007","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.005_bib77","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/lt.23854","article-title":"Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.005_bib78","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1600-6143.2010.03172.x","article-title":"Dimensions of antibody-mediated rejection","volume":"10","author":"Colvin","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.005_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V123574","article-title":"Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries","volume":"12","author":"Mauiyyedi","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4174\/astr.2015.88.2.100","article-title":"Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients","volume":"88","author":"Song","year":"2015","journal-title":"Ann Surg Treat Res"},{"issue":"8","key":"10.1016\/j.gtc.2017.01.005_bib81","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","article-title":"Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation","volume":"32","author":"Iacob","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOT.0000000000000275","article-title":"Prevention and treatment of liver allograft antibody-mediated rejection and the role of the \u201ctwo-hit hypothesis.\u201d","volume":"21","author":"Kim","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib84","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial","volume":"63","author":"De Pietri","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib85","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/hep.28291","article-title":"Transfusing common sense instead of blood products into coagulation testing in patients with cirrhosis: overtreatment \u2260 safety","volume":"63","author":"Rahimi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0012.1995.tb00296.x","article-title":"FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach","volume":"9","author":"Woodle","year":"1995","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.005_bib87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199707270-00014","article-title":"Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group","volume":"64","author":"Sher","year":"1997","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.005_bib88","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.005_bib89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.005_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985531730016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985531730016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T11:09:45Z","timestamp":1750244985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985531730016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S088985531730016X"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-Mediated Rejection After Liver Transplant","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}